Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study

BACKGROUND: Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. Given the chronic and heterogenous nature of the disease, treatment with various therapies is a frequent scenario in clinical practice. In persons with chronic morbidity such as MS patients, polypharmacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Frahm, Niklas, Hecker, Michael, Zettl, Uwe Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345436/
https://www.ncbi.nlm.nih.gov/pubmed/30677078
http://dx.doi.org/10.1371/journal.pone.0211120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345436/
https://www.ncbi.nlm.nih.gov/pubmed/30677078
http://dx.doi.org/10.1371/journal.pone.0211120

Ejemplares similares